A personalized melanoma vaccine paired with an immune checkpoint drug cut the risk of the cancer returning by 49 Percent at ...
We queried ClinicalTrials.gov to identify all completed or terminated phase III interventional studies investigating GECs (esophageal squamous cell carcinoma [ESCC], esophageal adenocarcinoma [EAC], ...
Part two in a series of articles highlighting frequently asked questions to comply with results reporting for ClinicalTrials.gov includes guidance on the Quality Control review process, protocol and ...
The Food and Drug Administration (FDA) announced in a news release dated April 13, 2026 that, on March 30, 2026, the agency issued reminders to more than 2,200 medical product companies and ...